COMMUNIQUÉS West-GlobeNewswire

The International Association for the Study of Lung Cancer Announces the IASLC 18th World Conference on Lung Cancer
13/07/2017
The only global meeting focused solely on lung cancer will convene thousands in Japan DENVER, July 13, 2017 (GLOBE NEWSWIRE) -- The International Association for the Study of Lung Cancer (IASLC) announced today that the [...]
Oriola Corporation revises guidance for continuing operations adjusted operating profit
13/07/2017
Oriola Corporation Stock Exchange Release 13 July 2017 at 19.00 Oriola Corporation revises guidance for continuing operations adjusted operating profit Despite the recent improvements in the performance of the Consumer [...]
Innate Pharma: Émission de 3 343 748 actions ordinaires au bénéfice de Novo Nordisk A/S en rémunération des droits sur l'anti-C5aR
13/07/2017
ÉMISSION PAR INNATE PHARMA DE 3 343 748 ACTIONS ORDINAIRES AU BÉNÉFICE DE Novo Nordisk A/S EN RÉMUNERATION DES Droits sur L'ANTI-C5 aR L'acquisition de l'anti-C5aR, un anticorps « first-in-class » au stade clinique, [...]
Issuance by Innate Pharma of 3,343,748 ordinary shares to Novo Nordisk A/S in consideration for rights in anti-C5aR
13/07/2017
Issuance by INNATE PHARMA of 3,343,748 ordinary shares to Novo Nordisk A/S in consideration for RIghts in ANTI-C5 aR The acquisition of the anti-C5aR, a first-in-class clinical-stage antibody, announced on June 2, 2017 [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 juin 2017
13/07/2017
Communiqué de presse Villepinte, le 13 juillet 2017 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]
Merus annonce les résultats financiers du premier trimestre 2017 et les résultats d'exploitation de mi-exercice
13/07/2017
Le bilan a été renforcé par un paiement initial de 120 millions de dollars et un achat de 80 millions de dollars d'actions auprès d'Incyte Corporation pour une collaboration de recherche stratégique mondiale en vue de [...]
Crown Bioscience Expands its Life Science Portfolio
13/07/2017
SANTA CLARA, Calif., July 13, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company [...]
IBA SA : IBA - NOTIFICATION DE TRANSPARENCE
13/07/2017
IBA - NOTIFICATION DE TRANSPARENCE Louvain-la-Neuve, Belgique, 11 juillet 2017, 17h40 - IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce [...]
IBA SA : IBA - TRANSPARENCY NOTIFICATION
13/07/2017
IBA - TRANSPARENCY NOTIFICATION Louvain-la-Neuve, Belgium, July 11, 2017, 5.40 p.m. - IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that [...]
Weifa ASA: Record second-quarter revenues driven by pain and cough & cold
13/07/2017
Oslo, 13 July 2017 Record second-quarter revenues of NOK 98.6 million (NOK 95.3 million) All-organic growth of 3.4% Second-quarter adjusted EBITDA of NOK 22.1 million (NOK 18.6 million) Adjusted EBITDA margin of 22.5% ( [...]
Vistin Pharma ASA : agreement to sell Opioids and CMO business - extended announcement
13/07/2017
Oslo, Norway, 13 July 2017 Reference is made to the stock exchange announcement on 11 July relating to the sale of Vistin Pharma ASA's ("Vistin Pharma" or "Company") opioids and tablet manufacturing business (CMO) ( [...]
Novartis CAR-T cell therapy CTL019 unanimously (10-0) recommended for approval by FDA advisory committee to treat pediatric, young adult r/r B-cell ALL
12/07/2017
Recommendation based on review of CTL019 r/r B-cell ALL development program, including the pivotal Phase II global ELIANA trial A Biologics License Application (BLA) for this indication is under FDA priority review; if [...]
Sanofi: Availability of the Pre-quarterly Results Communication
12/07/2017
Availability of the Pre-quarterly Results Communication Paris, France - July 12, 2017 - Sanofi announced today that its Pre-Quarterly Results Communication document is available on the "Investors" page of the company's [...]
Sanofi: Pre-quarterly Results Communication
12/07/2017
Paris, July 12, 2017 Pre-quarterly Results Communication Sanofi (EURONEXT: SAN and NYSE: SNY) has compiled the following items for consideration to assist in the financial modeling of the company's Q2 2017 results. [...]
Sanofi : Mise en ligne du document «Pre-quarterly Results Communication »
12/07/2017
Mise en ligne du document «Pre-quarterly Results Communication » Paris, France - Le 12 juillet 2017 - Sanofi annonce la mise en ligne sur l'espace Investisseurs du site internet de la société, d'un document intitulé « [...]
SPINEWAY : S1 2017 Bilan semestriel du contrat de liquidité
12/07/2017
Communiqué de Presse Ecully, 12 juillet 2017 BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE Au titre du contrat de liquidité confié par la société SPINEWAY à PORTZAMPARC Société de Bourse, à la date du 30 juin 2017 , les [...]
SPINEWAY:Liquidity contract half-yearly report
12/07/2017
Press release Ecully, 12 July 2017 LIQUIDITY CONTRACT HALF-YEARLY REPORT Regarding liquidity contract granted by SPINEWAY to PORTZAMPARC, the liquidity account held the following assets on 30th June 2017: 20 570 shares [...]
AB Science annonce l'obtention d'un nouveau brevet européen protégeant jusqu'en 2033 l'utilisation du masitinib chez les patients atteints du cancer du pancréas
12/07/2017
Paris, 12 juillet 2017, 17h45 AB Science annonce l'obtention d'un nouveau brevet européen protégeant jusqu'en 2033 l'utilisation du masitinib chez les patients atteints du cancer du pancréas et présentant une douleur [...]
AB Science announces issuance of a new European patent for protecting the use of masitinib in pancreatic cancer patients
12/07/2017
Paris, 12 July 2017, 5.45pm AB Science announces issuance of a new European patent for protecting the use of masitinib in pancreatic cancer patients with pain until 2033 Recruitment target before possible resampling of [...]

Pages